Modulation of Biofilm of Strains Isolated from Patients with Chronic Obstructive Pulmonary Disease by Levofloxacin,Moxifloxacin,Ciprofloxacin,Amoxicillin/Clavulanic Acid and Ceftriaxone
Free accessResearch articleFirst published online October, 2011
Modulation of Biofilm of Strains Isolated from Patients with Chronic Obstructive Pulmonary Disease by Levofloxacin,Moxifloxacin,Ciprofloxacin,Amoxicillin/Clavulanic Acid and Ceftriaxone
The ability of levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone to interfere on biofilm produced by Pseudomonas aeruginosa, Haemophilus influenzae and Streptococcus pneumoniae isolated from patients with chronic obstructive pulmonary disease was evaluated. The effects of antibiotics were evaluated on formation of biofilm (at 1/2, 1/4 and 1/8 X MIC) and on preformed biofilm (at epithelial lining fluid peak concentrations) by means of a spectrophotometric method. Levofloxacin was the most active compound followed by ciprofloxacin, moxifloxacin and amoxicillin/clavulanic acid and ceftriaxone. Levofloxacin may contribute to clear the reservoir of pathogens involved in chronic obstructive pulmonary disease, thus leading to decreased occurrence of acute exacerbations.
PuhanMAVollenweiderDLatshangTSteurerJSteurer-SteyC. Exacerbations of chronic obstructive pulmonary disease: When are antibiotics indicated? A systematic review. Respir Res2007; 8:30.
2.
SethiSEvansNGrantBJMurphyTF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med2002; 347:465–71.
CostertonJWStewartPSGreenbergER, Bacterial biofilms: A common cause of persistent infections. Science1999; 284:1318–22.
5.
DunneWM. Bacterial adhesion: Seen any good biofilms lately?Clin Microbiol Rev2002; 15:155–66.
6.
StewartPS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol2002; 292: 107–13.
7.
FuxCACostertonJWStewartPSStoodleyP. Survival strategies of infectious biofilms. Trends Microbiol2005; 13:34–40.
8.
AslamS. Effect of antibacterials on biofilms. Am J Infect Control2008; 36:S 175e9–11.
9.
PrinceAS. Biofilms, antimicrobial resistance, and airway infection. N Engl J Med2002; 347:1110–1.
10.
AnderlJNFranklinMJStewartPS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother2000; 44:1818–24.
11.
DalesLFerrisWVandemheenKAaronSD. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis. Eur J Clin Microbiol Infect Dis2009; 28:1275–79.
12.
KajiCWatanabeKApicellaMAWatanabeH. Antimicrobial effects of fluoroquinolones for the eradication of non-typeable Haemophilus influenzae isolates within biofilms. Tohoku J Exp Med2008; 214:121–28.
13.
MaestreJRMateoMMéndezMLAguilarLGimenezMJAlouLCoronePGranizoJJPrietoJ. In vitro interference of beta-lactams with biofilm development by prevalent community respiratory tract isolates. Int J Antimicrob Agents2010; 35:274–77.
14.
MinardiDMontanariMPTiliECochettiIMingoiaMVaraldoPEMuzzonigroG. Effects of fluoroquinolones on bacterial adhesion and on preformed biofilm of strains isolated from urinary double J stents. J Chemother2008; 20:195–201.
15.
Perez-GiraldoCGonzalez-VelascoCSanchez-SilosRMHurtadoCBlancoMTGomez-GarciaAC. Moxifloxacin and biofilm production by coagulase-negative staphylococci. Chemotherapy2004; 50: 101–4.
16.
Rodriguez-MartinezJMBallestaSPascualA. Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavualnic acid and cotrimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms. Int J Antimicrob Agents2007; 30:366–68.
17.
RovetaSSchitoAMMarcheseASchitoG. Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. Int J Antimicrob Agents2007; 30:415–21.
18.
ChristensenGDSimpsonAWYoungerJJBaddourLMBarrettFFMeltonDMBeacheyEH. Adherence of coagulase negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical device. J Clin Microbiol1985;22:996–1006.
19.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. M100-S15, CLSI Wayne2005.
20.
GotfriedMHDanzigerLHRodvoldKA. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects. Chest2001; 119:1114–22.
21.
CapitanoBMattoesHMShoreEO'BrienABramanSSutherlandCNicolauDP. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. Chest2004; 125:965–73.
22.
FraschiniFScaglioneFFalchiMDugnaniSMezzettiMCicchettiFAlfanoGPintucciGP. Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man. J Chemother1990; 2:171–77.
23.
ArcidiaconoMMDemartiniGDugnaniSScaglioneF. Legame sieroproteico e diffusione extravasale del cefodizime e del ceftriaxone in bronchitici cronici. Geriatria1996; 8:455–62.
24.
HsuJCNelsonB. Multiple Comparisons in the General Linear Model. J Comp Graph Stat1998; 7: 23–41.
25.
SAS Institute Inc. SAS 9.1.3 Help and Documentation, Cary, NC: SAS Institute Inc., 2000–2004.
AlbertsonTELouieSChanAL. The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis. J Am Geriatr Soc2010; 58:570–79.
28.
YassienMKhardoriN. Interaction between biofilms formed by Staphylococcus epidermidis and quinolones. Diagn Microbiol Infect Dis2001; 40:79–89.
29.
Di BonaventuraGSpedicatoID'AntonioDRobuffoIPiccolominiR. Biofilm formation by Stenotrophomonas maltophilia: Modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob Agents Chemother2004; 48:151–60.
30.
WangDWangYLiuYN. Activity of ciprofloxacin and azithromycin on biofilms produced in vitro by Haemophilus influenzae. Chin Med J2009; 122: 1305–10.
31.
Butorac-PetanjekBParnhamMJPopovic-GrleS. Antibiotic therapy for exacertbations of chronic obstructive pulmonary disease (COPD). J Chemother2010;22:291–97.
32.
ParameswaranG IyerMurphyTF. Chronic obstructive pulmonary disease: Role of bacteria and updated guide to antibacterial selection in the older patient. Drugs Aging2009; 26:985–95.
33.
LiXJLiQSiLYYuanQY. Bacteriological differences between patients with acute exacerbations of COPD and community acquired pneumonia. Respir Care2011; Epub.
34.
SethiSMurphyTF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med2008; 359:2355–65.
35.
EngRHKPadbergFTSmithSMTanENCherubinCE. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother1991; 35:1824–28.
36.
GilbertPBrownMR. Biofilms and β-lactams activity. J Antimicrob Chemother1998; 41:571–72.
37.
El-FekyMAEl-RehewyMSHassanMAAbolellaHAAbd El-BakyRMGadGF. Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Pol J Microbiol2009; 58:261–67.
38.
ZhaoTLiuY. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol2010; 10:140.
